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Abstract
The peptidoglycan (PG) sacculus provides bacteria with the
mechanical strength to maintain cell shape and resist osmotic
stress. Enlargement of the mesh-like sacculus requires the
combined activity of peptidoglycan synthases and hydrolases. In
Escherichia coli, the activity of two PG synthases is driven by
lipoproteins anchored in the outer membrane (OM). However, the
regulation of PG hydrolases is less well understood, with only regu-
lators for PG amidases having been described. Here, we identify
the OM lipoprotein NlpI as a general adaptor protein for PG hydro-
lases. NlpI binds to different classes of hydrolases and can specifi-
cally form complexes with various PG endopeptidases. In addition,
NlpI seems to contribute both to PG elongation and division
biosynthetic complexes based on its localization and genetic inter-
actions. Consistent with such a role, we reconstitute PG multi-
enzyme complexes containing NlpI, the PG synthesis regulator
LpoA, its cognate bifunctional synthase, PBP1A, and different
endopeptidases. Our results indicate that peptidoglycan regulators
and adaptors are part of PG biosynthetic multi-enzyme complexes,
regulating and potentially coordinating the spatiotemporal action
of PG synthases and hydrolases.
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Introduction
Peptidoglycan (PG) provides bacteria with the mechanical strength
to maintain cell shape and resist osmotic stresses. The PG layer or
sacculus is a mesh-like structure composed of glycan chains
connected by peptides and surrounds the cytoplasmic membrane
(CM; Vollmer et al, 2008a; Silhavy et al, 2010). Given the internal
turgor of the cells, PG layer growth requires the coordinated action
of synthases and hydrolases to enlarge the sacculus without rupture.
This important task is executed by large protein complexes, the
elongasome and the divisome, which recruit PG enzymes together
with regulators, cytoskeletal, morphogenesis and other structural
proteins (Typas et al, 2012; Typas & Sourjik, 2015; den Blaauwen
et al, 2017). It has been previously hypothesized that the formation
of these complexes enables the cell to coordinate and regulate the
activities of various synthetic and hydrolytic PG enzymes in a
spatiotemporal manner (Ho¨ltje, 1993). Within these complexes, the
key bifunctional penicillin-binding protein (PBP) PG synthases are
activated by cognate outer membrane (OM)-anchored lipoproteins
(Paradis-Bleau et al, 2010; Typas et al, 2010, 2012; Dorr et al, 2014;
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Egan et al, 2014, 2018; Greene et al, 2018; More´ et al, 2019) and
coordinate their action with another, cell constriction-related protein
complex (Gray et al, 2015). However, with the exception of the
amidases (Uehara et al, 2010; Yang et al, 2012; Peters et al, 2013;
Tsang et al, 2017), it is less clear how Gram-negative bacteria
control the activities of their repertoire of hydrolases, i.e. the
endopeptidases (EPases), carboxypeptidases (CPases) and lytic
transglycosylases.
NlpI is an OM-anchored lipoprotein predicted to be involved in
cell division and responsible for targeting the PG EPase MepS for
proteolytic degradation (Ohara et al, 1999; Singh et al, 2015). Dele-
tion of nlpI causes cell filamentation at elevated temperature (42°C)
or low osmolarity, whilst overexpressing NlpI results in the forma-
tion of prolate spheroids (Ohara et al, 1999). Deletion of nlpI has
further implications on the stability of the OM as it increases
membrane vesicle formation, in a manner that depends on the activ-
ity of two EPases; PBP4 in stationary phase and MepS in exponential
phase. This vesicle formation phenotype is suppressed by a deletion
of mepS (Schwechheimer et al, 2015). Many of its pleiotropic effects
may be due to the ability of NlpI to target the EPase MepS for prote-
olytic degradation by forming a complex with the tail-specific
protease Prc (Su et al, 2017). NlpI and MepS both interact with Prc,
but whilst MepS is digested, only 12 C-terminal amino acids of NlpI
are removed (Singh et al, 2015). In the absence of NlpI, the half-life
of MepS increases from ~2 min to ~45 min. Further, in the DnlpI
mutant, uncontrolled levels of MepS have been shown to impair cell
growth on low osmolarity medium and lead to the formation of long
filaments (Singh et al, 2012, 2015).
NlpI forms a homodimer (Wilson et al, 2005) with the 33 kDa
monomers having their OM-binding N-termini in close proximity.
Each monomer consists of 14 a-helices forming 4 canonical but
distinct tetratricopeptide helix-turn-helix repeats (TPR) and 2 non-
TPR helix motifs. TPR are found in many protein-interacting
modules (Zeytuni & Zarivach, 2012). A putative binding cleft is
formed from the curvature of the helices on each monomer, which
would be available for protein–protein interactions (Das et al, 1998;
Wilson et al, 2005). It is hence possible that NlpI acts as a scaffold
for the formation of protein complexes. In this study, we provide
evidence that in addition to targeting MepS for degradation, NlpI
scaffolds hydrolases within PG multi-enzyme complexes in E. coli.
Results
Deletion of NlpI alters abundance and thermostability of
envelope biogenesis proteins
Deletion of nlpI causes several pleiotropic phenotypes and morpho-
logical changes. To link the observed phenotypes to changes in
protein abundance and activity, we compared an nlpI knockout
strain (ΔnlpI) to wild-type E. coli using two-dimensional thermal
proteome profiling (2D-TPP; Savitski et al, 2014; Mateus et al,
2018). In TPP, both protein abundance and thermostability can be
measured. The latter depends on the intrinsic physical properties of
the protein and on external factors that stabilize its fold, such as
protein–protein and protein–ligand interactions.
Numerous proteins changed abundance and thermostability in
the DnlpI cells (Tables EV1 and EV2). In agreement with its
periplasmic location and links to envelope integrity (Schwechheimer
et al, 2015), deletion of nlpI resulted in changes in abundance and
thermostability of major envelope components, including outer
membrane proteins (OMPs), the b-barrel assembly machinery
(BAM; Noinaj et al, 2017) and the Tol-Pal complex (Egan, 2018;
Fig 1A and B). As expected, both MepS abundance and thermosta-
bility were dramatically elevated in DnlpI cells, since in the absence
of NlpI, MepS is not targeted for degradation by Prc (Singh et al,
2015; Fig 1A and B). We also observed that other PG biogenesis
proteins showed mild increases in abundance and these included
several PG hydrolases (PBP5, PBP6a, MltA, MltG), LdtB, LdtF and
PG synthases (PBP1A, PBP1B; Fig 1A). A number of these also
decreased in thermostability, with lytic transglycosylases (MltA,
MltC, MltE), the LD-transpeptidase LdtF and the PG synthases and
their regulators (PBP1B, LpoA, LpoB) showing the strongest effects
(Fig 1B). In contrast, all amidases (AmiA, AmiB and AmiC)
decreased in abundance (Fig 1A). Moreover, the amidase regulator
NlpD (which binds to AmiC and controls its activity; Uehara et al,
2010) and the YraP protein, which was recently implicated in the
activation of NlpD, were strongly destabilized (Fig 1B; Tsang et al,
2017).
To ensure that pleiotropic changes are not due to polar gene
expression caused by inactivation of NlpI, we complemented the
DnlpI mutant by expressing endogenous NlpI from an arabinose
inducible, medium copy number plasmid (pBAD30). The comple-
mented strain restored cell length and partially cell width to wild-
type values (Appendix Figs S5F, and S12A and B). The lack of full
complementation of cell widths could be due to our inability to
precisely restore the level and regulation of NlpI and, consequently,
the level of MepS (Ohara et al, 1999), Overall, our results indicate
that almost all effects in the DnlpI mutant are due to cells lacking
NlpI.
To test whether the observed changes are due to higher abun-
dance of MepS in the DnlpI mutant, we repeated the 2D-TPP with
an DnlpIDmepS mutant (Appendix Fig S1A and B). Several of the
changes observed in the DnlpI cells remained in the DnlpIDmepS
background (Appendix Fig S1A and B), including the destabilization
of many cell wall enzymes and regulators. We also directly
compared the 2D-TPP profiles of DnlpI and DnlpIDmepS mutants
(Appendix Fig S1C and D), with the major difference between both
proteomes being that some OMPs were more stable in DnlpI cells.
Importantly, the stability changes occurring for PG enzymes were
not observed in this comparison, indicating that they occur indepen-
dently of MepS levels. Altogether, these results provide the first
evidence that NlpI affects PG biogenesis beyond the known interac-
tion with the EPase MepS.
NlpI pulls down several classes of PG hydrolases and multiple
divisome proteins
The decrease in thermostability of several PG biogenesis
proteins in DnlpI cells raised the possibility that NlpI may
interact with these proteins. To investigate this further, we
applied detergent-solubilized E. coli membrane proteins to
immobilized NlpI to identify potential interaction partners.
Affinity chromatography was performed both in low salt bind-
ing conditions (50 mM) to pull down larger PG multi-enzyme
complexes, and in high salt binding conditions (400 mM) to
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identify stronger, salt-resistant and possibly direct binding part-
ners. As a control, we used a column containing Tris-coupled
sepharose beads and compared elution fractions with label-free
mass spectrometry (Tables EV3 and EV4). To investigate rele-
vant NlpI interaction partners, we first performed gene ontology
(GO) enrichment analysis and confirmed that proteins pulled
down are enriched in several relevant GO terms, such as “cell
wall organization” and “peptidoglycan metabolic processes”
(Tables EV9 and EV10). Next, we focused on proteins located
in the periplasmic space and highlighted known PG biogenesis
proteins (Fig 1C and D). For both affinity chromatography
experiments, we were unable to detect the known NlpI binding
partner MepS in the applied extract, likely due to its low cellu-
lar levels in wild-type cells (Fig 3D).
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Figure 1. In vivo and in vitro proteomics-based assays link NlpI to several classes of PG hydrolases.
A, B Wild-type and DnlpI cells were heated at a range of temperatures, and the soluble components were labelled by TMT, combined and quantified by LC-MS, using
the published 2D-TPP protocol (Mateus et al, 2018). Shown are volcano plots of two replicates depicting changes in protein abundance (A) and thermostability (B).
A local FDR (false discovery rate) < 0.01 was set as a threshold for significance. Highlighted proteins: outer membrane proteins (OMPs, light green), b-barrel
assembly machinery (BAMs, red), PG synthases/regulators (green), PG hydrolases and regulators (blue) and the Tol-Pal complex (violet). All other proteins were
coloured grey and not labelled to increase the plot clarity. Full results can be found in Tables EV1 and EV2.
C, D Affinity chromatography with immobilized NlpI. Membrane extracts from E. coli were incubated in low and high salt binding conditions (50 and 400 mM NaCl,
respectively), and then eluted with 1 M NaCl or 2 M NaCl to identify possible interaction partners by label-free LC-MS analysis. The plot shows the log2 fold
enriched proteins when compared to those eluted from a parallel empty column control, versus the log10 P-value, in low (4 replicates) (C) and high (2 replicates)
(D) salt. Highlighted points are all interactions with PG enzymes and their regulators, as well as members of the divisome. All other proteins were coloured grey
and not labelled to increase the plot clarity; many were non-physiological interactions with abundant cytoplasmic proteins. Full results can be found in Tables EV3
and EV4. GO enrichments can be found in Tables EV9 and EV10.
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In low salt binding conditions, NlpI retained several envelope
biogenesis proteins, such as the PG synthases PBP1A, PBP1B,
PBP1C, the divisome proteins EnvC, PBP3, FtsK, FtsQ and FtsX, the
lytic transglycosylases MltA and MltC, the amidase AmiC and the
EPases PBP4 and PBP7, amongst others (Fig 1C). This shows that
NlpI is able to pull-down full or partial PG-synthase complexes.
When challenged in high salt binding conditions, many of the afore-
mentioned interactions were lost. However, immobilized NlpI still
retained the divisome proteins PBP3, FtsK, FtsQ and FtsX, the
amidase AmiA and its regulator EnvC, and the lytic transglycosy-
lases MltA at 400 mM NaCl, suggesting strong, salt-resistant interac-
tions (Fig 1D).
The in vivo proteomics of DnlpI and the subsequent affinity chro-
matography revealed strong links of NlpI to several classes of PG
hydrolases, PG synthases and divisome proteins. To investigate
whether NlpI has a broader role in regulating EPases beyond MepS
(Singh et al, 2015), we next focused on characterizing the interac-
tions of NlpI with EPases and PG synthases in more detail.
NlpI dimerizes and interacts with several EPases
To confirm the observed interactions between NlpI and EPases, we
performed various biochemical assays. A soluble version of NlpI
lacking its membrane anchor was used for all these assays. Firstly,
we determined that NlpI is predominantly a homodimer using
analytical ultracentrifugation (AUC). The experimentally determined
sedimentation coefficient was 4.16 S, which is close to the calcu-
lated sedimentation coefficient of 4.52 S, based on the crystal struc-
ture of the NlpI dimer (1XNF.pdb; Wilson et al, 2005)
(Appendix Fig S2A). We measured the apparent dissociation
constant (KD) for the NlpI dimer as 126  9 nM by microscale ther-
mophoresis (MST): titrating a fluorescently labelled NlpI (fl-NlpI)
against a serial dilution of unlabelled NlpI (Fig 2A and Appendix Fig
S2B). Binding of the unlabelled NlpI to fl-NlpI resulted in changes to
the thermophoretic mobility of fl-NlpI, which is expressed as a
change in fluorescence and plotted against ligand concentration to
derive the binding affinity. The formation of a dimer by NlpI in solu-
tion is consistent with previous work (Su et al, 2017). We next
tested the specificity of a previously reported interaction between
NlpI and the EPase MepS, using MST (Singh et al, 2015). We found
that NlpI and MepS interacted directly, with an apparent KD of
145  52 nM (Fig 2A and B). NlpI also interacted with MepM and
PBP4 with similar apparent KD’s of 152  42 nM and 177  49 nM,
respectively (Fig 2A and Appendix Fig S2B). Assaying for an inter-
action between NlpI and PBP7 by MST revealed a more complex
binding curve, which could only be fit assuming a Hill coefficient of
~ 3 (Appendix Fig S2B). This resulted in an apparent EC50 value of
422  25 nM and suggested an element of positive cooperativity in
the NlpI-PBP7 binding.
We also tested the interactions between NlpI and EPases (MepM,
MepS, PBP4 and PBP7) by Ni2+-NTA pull-down assays and con-
firmed the interactions found by MST (Appendix Fig S3A). We could
not detect an interaction between NlpI and the carboxypeptidase
PBP5 or the lytic transglycosylase Slt, suggesting that NlpI does not
interact with all hydrolases in general (Appendix Fig S3A). Using a
combination of MST and Ni2+-NTA pull-down assays, we also
tested for interactions between the EPases. Of the four EPases,
which we studied and all possible combinations tested, the only
interactions we found were between MepS-MepM and PBP4-PBP7
(Appendix Figs S2C and S3B).
NlpI scaffolds trimeric complexes between different EPases
Since NlpI bound multiple EPases, we tested whether NlpI could
also form trimeric complexes with them. As a starting point, we
tested whether NlpI could scaffold MepS and PBP4 in a fixed
concentration MST assay. In the presence of 3 lM NlpI, the normal-
ized fluorescence (FNorm) of fl-MepS increased, confirming the
interaction between NlpI and MepS (Fig 2C). In contrast, fl-MepS
did not interact with PBP4, even when that was used in excess
(30 lM; Fig 2C). Interestingly, fl-MepS was able to bind to a satu-
rated NlpI-PBP4 complex indicating the formation of a trimeric
complex between NlpI, PBP4 and MepS (Fig 2C). NlpI pre-incubated
with excess BSA did not give the same increase in fl-MepS signal,
indicating that the FNorm increase was specific to the binding of
NlpI-PBP4 (Fig 2C). We also tested whether NlpI was able to scaf-
fold MepS and PBP7. Fl-MepS could bind pre-incubated NlpI-PBP7
complexes indicating that NlpI can scaffold both EPases and likely
has different binding sites for MepS and PBP7 (Fig 2D). Using a
three-component Ni2+-NTA pull-down assay, we were also able to
resolve an NlpI-mediated complex containing PBP7 and MepS
(Appendix Fig S3C). The trimeric complexes were not due to direct
interactions between the EPases (Appendix Fig S2C and S3B), but
rather due to NlpI scaffolding both EPases simultaneously. Thus,
NlpI can scaffold at least two different trimeric EPase complexes,
with MepS-PBP4 and MepS-PBP7.
NlpI affects EPase activity of MepM and MepS in vitro
Although NlpI interacted with and complexed several EPases, the
cellular role of such complexes remained unclear. Hence, we inves-
tigated whether NlpI increased or decreased the activity of these
EPases using in vitro PG digestion assays with purified sacculi or
pre-digested muropeptides. EPases cleave the peptide bond between
neighbouring peptides, resulting in a decrease in TetraTetra (bis-
disaccharide tetrapeptide) muropeptides. Therefore, we quantified
the remaining cross-linked PG substrate following incubation with
the respective EPase and used the decrease in TetraTetra as an indi-
cation of EPase activity (Fig 3A and Appendix Fig S4A). Our results
show that NlpI reduced the activity of MepM, which was more
active by itself against sacculi. In contrast, MepS was inactive
against sacculi and pre-digested muropeptides, but the addition of
NlpI slightly activated MepS against muropeptides (Fig 3A; see also
methods). We did not observe significant differences in the activity
of PBP4 or PBP7 in the presence of NlpI (Fig 3A). These results
suggest that NlpI is able to modulate the activity in vitro of certain
(e.g. MepM and slightly MepS), but not all, EPases.
NlpI genetically interacts with EPases and its absence alters
cell morphology
To address whether NlpI-EPase complexes are relevant for fitness in
E. coli, we deleted nlpI in combination with different EPases and
compared the fitness of the double mutants with that of the parental
single mutants (Fig 3B). Only nlpI and mepS exhibited a strong posi-
tive genetic interaction with the double-mutant DnlpIDmepS
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growing as well as the DmepS mutant, and better than the DnlpI
mutant. The other mutant pairs exhibited none to very mild genetic
interactions based on fitness assays (Fig 3B). To investigate whether
more genetic interactions existed but were not visible in fitness
assays, we looked for changes at the single-cell level. To do this, all
NlpI-EPase single and double mutants were grown exponentially
and their morphology was assessed using phase-contrast micro-
scopy (Appendix Fig S3C and S12C). First, we noticed that all tested
DnlpIDEPase double mutants were almost as thin as DnlpI cells (i.e.
5–10% thinner than wild type—hence no genetic interaction),
except for the DnlpIDmepS mutant, which was even wider than the
DmepS single mutant (Fig 3C). This strong genetic interaction is in
line with the fitness data (Fig 3B) and further points to the pheno-
types in the nlpI mutant being beyond mis-regulated MepS. Some
more subtle genetic interactions between nlpI and EPases were also
apparent. Deleting nlpI in DmepM mutants produced a subpopula-
tion of filamentous cells (Appendix Fig S12C). We also noted that
DpbpG mutants were shorter and fatter than wild type, but double
mutants with DnlpI exhibited only the expected additive effects
(Fig 3C and Appendix Fig S12C).
To further assess how much MepS levels interfere with the DnlpI
phenotype, we constructed an arabinose-inducible MepS plasmid
(pBAD30). We first confirmed that MepS is overexpressed and does
not cause strong fitness defects (Fig 3D and Appendix Fig S13A).
Next, we investigated whether MepS expression contributes to
morphological changes. Overexpression of MepS increased cell
length and slightly reduced cell width (Fig 3E and F, Appendix Fig
S13B and C), although not to the level of DnlpI mutants (Fig 3C).
Hence, DnlpI mutants and MepS overexpression strains share the
dramatic increase in MepS levels (Figs 1A and 3D) but the cell
morphology changes only to a certain extent. This further supports
that the DnlpI mutant phenotypes can be partially (but not fully)
explained by elevated MepS levels.
To further investigate whether the nlpI phenotypes go beyond
elevated MepS levels, we expanded the fitness genetic interaction
assays in selected growth conditions (Fig 3G). In low osmolality
medium (LB medium without salt), the DnlpI mutant was very sick
compared to wild-type cells (fitness ratio 0.31), likely due to
increased turgor pressure. This could be rescued by deleting mepS,
up to the fitness levels of the DmepS mutant (fitness ratio 0.77). In
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Figure 2. NlpI interacts with several EPases and is able to form trimeric complexes with them.
A Dissociation constants for interactions between NlpI with MepM, MepS, PBP4, PBP7 as determined by microscale thermophoresis (MST). The values are mean  SD
of three independent experiments. The corresponding MST binding curves are shown in Appendix Fig S2B.
B MepS-NlpI interaction by MST as an example plot for Fig 2A. The same plot is also shown in Appendix Fig S2B. MST curve plotted is the mean data  SD of three
independent experiments. Fl, fluorescently labelled; FNorm, normalized fluorescence.
C, D NlpI has different binding sites for MepS and PBP4, and MepS and PBP7 as shown by the ability of labelled MepS to bind pre-formed NlpI-PBP4 (C) and NlpI-PBP7
(D) complexes by a fixed concentration MST assay. Values are mean  SD of 3–6 independent experiments. To calculate significance, the data were fit using a
linear model. Calculated means were compared using Tukey’s HSD test, resulting in P-values corrected for multiple testing. Relevant P-values are highlighted
directly in the figure (*< 0.05; **< 0.01, ***< 0.001), and all P-values can be found in Table EV7.
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contrast, in high osmolality medium (LB medium with 500 mM salt
or LB with 10% sucrose) the DnlpI mutants’ fitness was restored to
wild-type levels (Fig 3G), and knocking out mepS did not cause any
further effects. Next, we tested if fitness phenotypes correlate to
defects in the envelope integrity of the tested mutants by using a
red-b-D-galactopyranoside (CPRG) envelope integrity assay (Par-
adis-Bleau et al, 2014). CPRG is a b-galactosidase substrate that fails
to penetrate wild-type cells, therefore being inaccessible to cytoplas-
mic b-galactosidase, which can hydrolyse CPRG and produce a red
colour (CPR). The production of CPR can be used as a readout for
envelope permeability and/or cell lysis. Knocking out mepS restored
the envelope integrity defects seen in the DnlpI mutant (Fig 3H).
Thus, in all our fitness assays the increased MepS levels are the
cause for the envelope integrity effects observed in the DnlpI
mutant.
In summary, our results provide evidence that cellular MepS levels
need to be tightly regulated by NlpI (and Prc), as imbalance causes
morphological changes, reduced envelope integrity and fitness.
However, although the fitness and envelope integrity defects of the
DnlpI mutant can be fully attributed to elevated MepS levels (at least
in assays and conditions we tested), the cell morphology phenotypes
(Fig 3C and F) and the global changes in protein abundance and stabil-
ity (Appendix Fig S1) cannot. Both point to MepS-independent effects
in the nlpI mutant. In agreement with this, nlpI seems to also geneti-
cally interact with other EPases (mepM) at the least at a morphological
level (Appendix Fig S12C). Thus, we conclude that NlpI has additional
effects on controlling cell shape beyond the described proteolytic regu-
lation of MepS (Singh et al, 2015).
NlpI localizes along the entire cell envelope
To understand further the physiological role of NlpI, we investigated
its cellular localization using specific antibodies. NlpI localized in
the entire envelope and not specifically at midcell (Fig 4A and
Appendix Fig S5), in contrast to what its interaction with some divi-
some proteins suggested (Fig 1D). In addition, its concentration
remained constant during the cell cycle (Appendix Fig S5A). To
control for possible epitope occlusion by interaction partners of
NlpI, we localized a functional C-terminal fusion of NlpI with an
HA-tag expressed from a plasmid in the ΔnlpI strain. The NlpI-HA
localization pattern was identical to that of NlpI (Appendix Fig
S5D). We noticed that the localization pattern of NlpI was reminis-
cent of the PBP synthases PBP1A and PBP2 (den Blaauwen et al,
2003; Banzhaf et al, 2012). Together with the links of NlpI to PG
synthases observed in TPP and pull-downs (Fig 1), this made us
wonder whether NlpI-EPase complexes can be part of PG machiner-
ies.
NlpI associates with PG machineries
To probe for genetic interactions with the PG synthetic machineries,
we deleted nlpI in combination with different PBPs and their regula-
tors (Lpos) and compared the fitness of the double mutants with
that of the parental single mutants (Fig 4B). We noticed an almost
synthetic lethality with ΔmrcB (encodes PBP1B) and ΔlpoB (encodes
LpoB), fitness ratio of 0.62 and 0.49, respectively. ΔmrcA (en-
codes PBP1A) and ΔlpoA (encodes LpoA) also exhibited strong
negative interactions with ΔnlpI, fitness ratio of 0.30 and 0.21,
respectively (Fig 4B). To analyse whether these strong negative
genetic interactions were also reflected in the morphology of the
cells, all single and double mutants were grown exponentially and
imaged by phase-contrast microscopy. Combining ΔnlpI with ΔmrcB
or ΔlpoB led to abnormal cell morphologies, with cells being 30%
wider and up to 80% longer (Fig 4C and Appendix Fig S12D). This
suggests that the NlpI-EPase complexes might be important for facil-
itating the formation of the PBP1A-mediated PG machinery. This
◀ Figure 3. NlpI genetically interacts with MepS and affects the enzyme activity of MepS and MepM.A HPLC-based PG digestion assay representing EPase activity. The graph shows the relative percentage of the muropeptide TetraTetra present at the end of the
incubation period for each protein as described in Materials and Methods. MepM and PBP4 were incubated with sacculi, whilst MepS and PBP7 were incubated with
soluble muropeptides, both from E. coli MC1061, respectively. Values are mean  SD of three independent experiments. Representative chromatograms are shown in
Appendix Fig S4. To calculate significance, the data were fit using a linear model. Calculated means were compared using Tukey’s HSD test, resulting in P-values
corrected for multiple testing. Relevant P-values are highlighted directly in the figure (*< 0.05; **< 0.01, ***< 0.001), and all P-values can be found in Table EV8.
B Genetic interactions of nlpI with EPase genes. Strains were arrayed using a Rotor HDA replicator on Lennox LB agar plates and incubated for 12 h at 37°C. Each plate
contained 384 colonies, 96 from the wild type, single mutants and double mutants. An example of a 384-well plate is shown. Double mutants were made twice,
swapping the resistance markers to the two single mutants. Colony integral opacity was quantified as a fitness readout, using the image analysis software Iris
(Kritikos et al, 2017). Bar plots show the averaged values of 2 biological experiments, each having 96 technical replicates (i = 2, n = 192). The error bars represent the
95% confidence interval. Full results can be found in Table EV5.
C nlpI deletion changes the morphology of EPase-mutant strains. The graph shows the cell width of single- and double-deletion strains (800 < n < 2,000 cells). The box
has a medium between 25 and 75%. The whiskers with the upper and lower vertical line indicating the 95 and 5%. The dots are individual points outside the 5 and
95% range. Above the graph are representative images of cells lacking MepS or PBP4 in combination with a deletion of NlpI. The same images for control and NlpI
mutant strains have been reused in Fig 4C. The scale bar equals 2 lm. Gene encoding protein legend: nlpI encodes NlpI, dacB encodes PBP4, pbpG encodes PBP7,
mepM encodes MepM, meps encodes MepS. Cell length of mutants is displayed in Appendix Fig S12c.
D Inducible mepS expression system (pBAD30) strongly overproduces MepS. Strains were grown in LB at 30°C, and cells were collected at OD6000.4. The level of MepS
contained in the membrane fraction was detected using purified anti-MepS antibody.
E Visualization of the effect of MepS absence or its overexpression on cell width by phase-contrast microscopy. Cultures were grown in LB at 30°C, and aliquots of
culture were taken at OD6000.1. The scale bar equals 5 lm.
F MepS level modulates cell width. The graph shows the distribution of mean cell width for each cell, with n corresponding to the number of cells measured for each
strain and the median width for the population being indicated by a dotted line and referred to as w.
G Relative fitness of DnlpI, DmepS and DnlpIDmepS mutants. Strains were arrayed using a Rotor HDA replicator on Lennox LB agar plates supplemented 10% sucrose, or
LB agar plates containing 0 mM or 500 mM NaCl. Plates were incubated for 12 h at 37°C. Each plate contained 384 colonies, 96 from the wild type, single mutants
and double mutants. Fitness ratios, bar plots and error bars were calculated/made as in (B). Full results can be found in Table EV5.
H Cells of wild type (WT), DnlpI, DmepS and DnlpIDmepS containing multicopy plasmids with lacZ were grown onto CPRG indicator agar to assay envelope integrity.
CPRG (yellow) cannot penetrate intact Gram-negative envelopes. Its conversion by intracellular b-galactosidase to CPR (red) indicates loss of envelope integrity.
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would be consistent with the changes in thermostability of PBP1A
and LpoA in ΔnlpI cells (Fig 1B). Thus, we next tested the in vitro
interactions between NlpI and respective EPases with PBP1A and
LpoA. We discovered that PBP1A did not directly interact with NlpI
but interacts with low nanomolar range affinities with different
EPases, including MepS (apparent KD = 91  39 nM), PBP4
(106  44 nM) and PBP7 (101  35 nM) (Fig 4D, Appendix Fig
S6A and S7). PBP4 (315  38 nM) and PBP7 (217  93 nM) also
bound to LpoA at slightly higher nM ranges (Fig 4D, Appendix Fig
S6B and S7). These interactions between PG synthases and EPases
would allow for PG multi-enzyme complexes to exist as postulated
by Hӧltje (Hӧltje, 1998).
NlpI is part of a PG multi-enzyme complex with PBP4
and PBP1A/LpoA
To further understand the interaction between PG hydrolases and
synthases, we characterized in detail the interactions between PBP4
with PBP1A/LpoA and NlpI by MST. We used a fixed concentration
MST assay to show that fluorescently labelled PBP1A and LpoA are
able to bind a pre-formed PBP4-NlpI complex (Fig 5A and B,
Appendix Fig S8A). Whilst the binding of PBP4 and PBP4-NlpI to fl-
PBP1A resulted in an increase in FNorm values (which was not the
case in the presence of NlpI alone), binding of PBP4 and PBP4-NlpI
to LpoA consistently resulted in an enhanced initial fluorescence.
This indicated that the ligand was binding in close proximity to the
probe and was affecting the local environment of the fluorophore
and subsequently its fluorescence yield. Since the change in fluores-
cence was due to ligand binding (Appendix Fig S8B), the raw fluo-
rescence data as opposed to the FNorm values were plotted in this
instance (Fig 5B). These consistent increases in fluorescence reflect
the binding of PBP4 and PBP4-NlpI to LpoA and suggest that the
presence of NlpI does not prevent the interaction of PBP4 with LpoA
A
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MepS 91 ± 39 No interaction
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Figure 4. NlpI localizes along the entire cell envelope and associates
with PG machineries.
A Phase-contrast image and corresponding fluorescence SIM image of
BW25113 cells that have been grown in LB at 37°C and immunolabelled
with specific antibodies against NlpI. Scale bar equals 2 lm. See
Appendix Fig S5 for further details.
B Genetic interactions of NlpI with PG machineries. Strains were arrayed and
assessed as in Fig 3b. An example of a 384 plate is shown. Bar plots show
the averaged values of 2 experiments (i = 2, n = 192). Error bars denote the
95% confidence interval of the mean. Full results can be found in
Table EV5.
C NlpI deletion exacerbates the morphological defects of the PBP1B/LpoB-
mutant strains. The graph shows the cell width of single- and double-
deletion strains (800 < n < 2,000 cells). The box has a medium between 25
and 75%. The whiskers with the upper and lower vertical line indicating
the 95 and 5%. The dots are individual points outside the 5 and 95% range.
Representative images of the strains are shown above the graph. The same
images for control and NlpI mutant strains have been reused in Fig 3C. The
scale bar equals 2 lm. Gene encoding protein legend: nlpI encodes NlpI,
mrcA encodes PBP1A, lpoA encodes LpoA, mrcB encodes PBP1B, lpoB
encodes LpoB. Cell length of mutants is displayed in Appendix Fig S12D.
D Dissociation constants for interactions between PBP1A and LpoA with NlpI,
MepM, MepS, PBP4 and PBP7 as determined by MST. The values are
mean  SD of three independent experiments. 1PBP1A was used as
fluorescently labelled protein in all assays. 2LpoA was used as unlabelled
ligand in all combinations, except with MepM and PBP4. Binding curves
are shown in Appendix Fig S6.
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(Fig 5B). Following on from the previous identification of a multi-
enzyme complex containing the synthase PBP1B, the lytic transgly-
cosylase MltA and the OM scaffold protein MipA (Vollmer et al,
1999), this is the only other biochemical evidence, to our knowl-
edge, that PG synthases and PG hydrolases form multi-enzyme
complexes with regulatory lipoproteins to possibly coordinate PG
synthesis in Gram-negative bacteria.
Discussion
Escherichia coli contains a repertoire of more than 20 periplasmic
hydrolases providing specificity to almost every bond present in PG
(Vollmer et al, 2008b; van Heijenoort, 2011; Singh et al, 2012;
Yunck et al, 2016; Chodisetti & Reddy, 2019). However, with the
exception of amidases, it is unclear how these hydrolases are regu-
lated to prevent autolysis (Uehara et al, 2009). This study identifies
NlpI as a novel scaffolding protein of EPases that might coordinate
hydrolases within PG synthesis machineries. NlpI is also able to
bind several other hydrolytic enzymes, including some members of
the amidase and lytic transglycosylase families. The details of these
interactions will be investigated in future work.
Deletion of nlpI impacts envelope biogenesis beyond the
proteolytic regulation of MepS levels
NlpI interacts with MepS and targets it for degradation via the
protease Prc (Singh et al, 2015). Inactivation of mepS leads to a
17% increase in cell diameter compared to wild-type cells (Fig 3C),
whereas overexpression of mepS reduced the cell diameter,
although not to the level of DnlpI mutants (Fig 3C and F). Neverthe-
less, the observed shape changes provide further evidence that
cellular MepS levels impact the cell diameter. On the other hand,
inactivating both, nlpI and mepS, increased the cell diameter up to
30% compared to wild-type cells (Fig 3C). Therefore, DnlpIDmepS
mutants did not phenocopy DmepS or DnlpI mutants in their shape
(Fig 3C and Appendix Fig S12C) and this indicates that inactivation
of nlpI leads to additional morphological effects. This is supported
by the observation that the DmepMDnlpI cells contain long fila-
ments, a phenotype not seen with either the parental single mutants
or the strain overexpressing MepS. In conclusion, the contribution
of NlpI to cell morphology goes beyond mis-regulated MepS levels.
DnlpI mutants are known to increase OM vesicle formation (Sch-
wechheimer et al, 2015) and shown here to have reduced fitness
(especially in hypoosmotic conditions) and envelope integrity
compared to wild-type cells (Fig 3B, G and H). All these effects are
due to elevated MepS levels, as they are fully resolved in the
DnlpIDmepS mutant. Thus, the envelope integrity defects of the
DnlpI mutants are mainly (if not entirely) due to elevated MepS
levels.
In summary, we show that the interplay of NlpI-MepS impacts
fitness, cell morphology and envelope integrity. However, DnlpID
mepS mutants do not phenocopy DnlpI or DmepS mutants and in
addition differed in many of the global changes in protein abun-
dance and stability compared to the DnlpI mutant or wild-type
cells. In addition, our biochemical evidence (protein–protein inter-
actions and protein activity assays) and genetic interactions
suggest that NlpI binds to a number PG hydrolases and synthases
and their regulators, affecting PG-related processes. NlpI binds to
and inhibits MepM in vitro, which is reflected by a positive
genetic interaction in vivo. NlpI also binds strongly to amidases
and their regulators (AmiA, EnvC; Fig 1B and D), lytic transglyco-
sylases (MltA, MltC; Fig 1B and D) and other EPases (PBP4,
PBP7; Fig 2, Appendix Fig S2 and S3), some in the context of PG
biosynthetic machineries (Figs 4–6). This raises the possibility that
NlpI scaffolds, or even regulates, several classes of hydrolases
beyond its function towards EPases. To the best of our knowl-
edge, this is the first evidence that NlpI has additional functions
in PG synthesis.
NlpI interacts with several EPases at physiologically
relevant concentrations
Immobilized NlpI retained the EPases PBP4 and PBP7, raising the
possibility that NlpI interacts with additional EPases along with
MepS (Fig 1C). Especially since MepS was not amongst the proteins
being pulled down, despite being known to bind to NlpI (Singh et al,
2015), we decided to investigate this further. Using MST and pull-
down assays, we validated interactions between NlpI and 3 other
DD-EPases; MepM, PBP4 and PBP7, all of them with apparent KD or
EC50 values in the nanomolar range (Fig 2C and Appendix Fig S2A).
We estimated the concentration of these proteins in the periplasm,
assuming cell dimensions of 4.77 × 106 m (length) and 1.084 ×
106 m (diameter), with a periplasmic width of 21 × 109 m (Bev-
eridge, 1995; Banzhaf et al, 2012; Fig 6A). We conclude that the
NlpI-EPase interactions identified in the present work are all, in
principle, able to occur in the cell (Fig 6A). Furthermore, our data
showed that NlpI could also affect the activity of some of these
EPases; for example, the activity of MepM against intact sacculi was
reduced in the presence of NlpI (Fig 3A). As NlpI facilitates the
proteolytic degradation of MepS (Singh et al, 2015), NlpI could be
generally restricting the role of cell elongation-related EPases (Singh
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Figure 5. PBP4 forms a PG multi-enzyme complex with NlpI
and PBP1A/LpoA.
A, B PBP4 has different interaction sites for PBP1A/LpoA and NlpI as shown by
a single concentration MST assay. Plots show the FNorm or fluorescence
values of fluorescently labelled PBP1A or LpoA with or without PBP4, NlpI
or PBP4-NlpI. Values are mean  SD of three independent experiments.
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et al, 2012). Consistently, the DnlpIDmepM was more filamentous
than its parental single mutants (Appendix Fig S12C).
With regard to activity of EPases, we note that we were unable
to observe the DD-EPase activity of MepS, previously reported in
Singh et al (2012) (Fig 3A). However, whilst addition of NlpI had
no effect on the activity of PBP4 or PBP7, there was a very slight
stimulation of MepS activity against isolated muropeptides in the
presence of NlpI, following overnight incubation (Fig 3A; see also
methods). Overall, these results raise the possibility that NlpI could
modulate the activity of specific hydrolases along with its role as a
scaffolding protein.
NlpI scaffolds multi-protein complexes with PG hydrolytic
enzymes within the context of PG biosynthesis machineries
NlpI is able to form trimeric complexes with different EPases that
lack mutual interactions. Examples of such complexes resolved in
the present work are MepS-NlpI-PBP4 and MepS-NlpI-PBP7 (Fig 2C
and D). Since NlpI has four helix-turn-helix TPR-like repeats per
monomer, it remains to be seen whether the different TPR helixes
are specific for different binding partners (Wilson et al, 2005) and/
or different type of hydrolytic enzymes. Nevertheless, the ability of
NlpI to bind multiple ligands simultaneously is consistent with the
idea that TPR domains facilitate the formation of multi-protein
complexes (Blatch & Lassle, 1999; Cortajarena & Regan, 2006). In
this sense, NlpI is more promiscuous in nature than the previously
identified amidase regulators EnvC and NlpD, which have specificity
to their cognate amidases (Uehara et al, 2009).
Despite binary interactions between various EPases and PBP1A/
LpoA being able to occur in the absence of NlpI (Fig 4D), we
hypothesize that NlpI could sequester additional or specific sets of
EPases and other hydrolytic enzymes, determining the specificity of
such synthetic machineries. Accordingly, our finding that PBP4 is
able to simultaneously bind PBP1A/LpoA and NlpI supports the
idea that NlpI could specifically scaffold hydrolases at active PG
synthases (Fig 5A and B). The ability of an OM-anchored NlpI to
complex EPases and other hydrolases would not only serve to
locally concentrate those enzymes near PG synthesis complexes, but
also to maintain the active hydrolases in the space between the PG
layer and OM, facilitating cleavage of the mature PG of the sacculus
and keeping them at distance to the newly synthesized PG, which
emerges between the CM and PG layer and is not subject to turn-
over. NlpI molecules are outnumbered by the amount of potential
binding partners in the periplasm, so it is unlikely that there is an
abundance of free NlpI (Fig 6A). EPase regulation might occur on
the level of binding affinity to NlpI and its TPR-like domains. This
would see NlpI resembling a “dock” for EPases (and possibly other
hydrolases) to make them available for PG synthesis complexes
when needed. Such a system would allow for greater flexibility, as
NlpI interacts with many hydrolases. Alternatively, the specificity
could be encoded on the level of the hydrolases. As demonstrated,
EPases interact directly with PG synthases, but those interactions
might be specific to particular EPases (and no other hydrolases)
and/or might be subject to environmental cues or to competition for
the same binding site. Therefore, NlpI could be a more general
adaptor of hydrolases, as suggested by its interactions with
amidases and lytic transglycosylases (Fig 1B and D), bringing a set
of hydrolases to biosynthetic complexes. It is worth noting that loss
of nlpI has no significant effects on PG composition (Appendix Fig
S11), suggesting the primary role of NlpI is in the coordination of
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Figure 6. Proposed model for a role of NlpI in coordinating formation of PG multi-enzyme complexes containing EPases.
A Estimated number of molecules and molarity of PBP1a/LpoA and EPases. 1Numbers obtained by ribosomal profiling in rich growth medium (Li et al, 2014).
2Concentration of monomer. 3Decreases in the presence of NlpI (Singh et al, 2015). 4“no change detected”. The periplasmic concentrations of proteins were estimated
for a cell with periplasmic volume of 3.33 × 1016 l, where 1 molecule corresponds to 5 nM.
B Hypothetical model of NlpI scaffolding endopeptidases during cell elongation. Black arrows indicate interacting proteins with numbers indicating apparent EC50/KD
values. OM, outer membrane; CM, cytoplasmic membrane. MepS–PBP1A interaction is not represented due to illustrative restrictions.
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multi-protein complex formation and not in the regulation of a
specific hydrolase. It will require more work to test this hypothesis
in the future.
Around 20 years ago, Hӧltje hypothesized that growth of the PG
sacculus requires both synthases and hydrolases working in tandem
to enable a safe and coordinated enlargement (Hӧltje, 1998).
However, it has also been suggested that EPases are not necessarily
part of multi-protein complexes, as overproduction of three different
EPases confers mecillinam resistance (Lai et al, 2017). In this work,
we provide the first evidence of interactions between PBP1A/LpoA
with PBP4 and hypothesize that interactions between NlpI and other
EPases could facilitate their delivery to PG synthesis complexes
during PG growth. The existence of PG multi-protein complexes is
not mutually exclusive with the idea that EPases and/or NlpI-EPase
complexes may in part also localize outside of such PG assembly
machineries. This work, and the work of others, supports the idea
that PG multi-protein complexes are highly dynamic and driven by
transient protein–protein interactions (Pazos et al, 2017). We note
that the respective EPases also have known interactions with other
PG processing enzymes, beyond NlpI (Romeis and Hӧltje, 1994; von
Rechenberg et al, 1996), and these interactions could also be scaf-
folded by NlpI or other adaptor proteins, to contribute to the coordi-
nation of their activity within complexes. In addition, the existence
of such PG multi-protein complexes is in line with the previous
isolation of an 1 MDa cell division complex (Trip & Scheffers, 2015).
NlpI functions together with the PBP1A/LpoA PG machinery
We studied the localization of NlpI to infer whether NlpI scaffolds
complexes exclusively for cell elongation or division. The localiza-
tion pattern of NlpI is spotty and diffusive with no enrichment at the
midcell (Fig 4A). NlpI was previously shown to be located in the
OM of bacterial cells and is a known lipoprotein (Ohara et al, 1999;
Teng et al, 2010). It is hence also possible that interactions between
NlpI and hydrolases concentrate and facilitate cleavage from the
outer face of the PG layer. Its disperse localization would enable
binding of EPases involved in both division and elongation. NlpI
was shown to bind a number of essential divisome proteins at high
salt concentrations in our affinity chromatography experiment
(Fig 1D). This is consistent with the finding that DnlpI mutants were
initially discovered and classified as a filamentous temperature-
sensitive (fts) protein linking it to be conditionally essential for cell
division (Ohara et al, 1999). The same filamentous phenotype can
be observed in low osmolarity (Ohara et al, 1999). However, NlpI
localization was not enriched at the septum (Fig 4A), suggesting
that NlpI might be a transient member of the divisome or interacts
with cell division proteins away from midcell in non-dividing cells,
and NlpI could also have a main role in PG synthesis during cell
elongation. Indeed, the negative genetic interactions of nlpI with
mrcA (PBP1A) and mrcB (PBP1B) raise the possibility that NlpI can
affect both the elongasome and the divisome. This is in line with
both PBP1B/LpoB and PBP1A/LpoA complexes showing changes in
thermostability in DnlpI cells (Fig 1B). However, because the
genetic interactions of nlpI with mrcB (PBP1B) were stronger and
led to a near synthetic lethality, we reasoned that NlpI predomi-
nantly worked with the PBP1A/LpoA machinery. Cells lacking
PBP1B depend on a functional PBP1A/LpoA complex to achieve
growth (Yousif et al, 1985). An alternative scenario is that cells with
only PBP1A/LpoA are more sensitive to genetic and chemical
perturbations in the cell wall than cells with only PBP1B/LpoB,
because the latter is more efficient. Although we found no direct
interaction between NlpI with PBP1A or LpoA by MST assay (Fig 4D
and Appendix Fig S6), a complex of NlpI-PBP4-PBP1A could be
formed with PBP4 as the linking protein (Fig 5). The multitude of
interactions between PBP1A/LpoA, different EPases and NlpI
(Fig 4D and Appendix Fig S6) could enable the formation of dif-
ferent active synthase–hydrolase complexes under a range of growth
conditions or availability of particular proteins (Pazos et al, 2017).
We note that NlpI in the presence or absence of catalytically inac-
tive MepS(C68A) (MepS*) did not affect the GTase nor TPase activi-
ties of PBP1A-LpoA (Appendix Figs S9 and S10, Table EV6), at least
in the conditions we tested. This suggests that NlpI’s importance to
the PBP1A/LpoA system is not as clearly discernible in vitro as it is
in vivo (Fig 4) and this may reflect a more dynamic role as an adap-
tor protein facilitating the formation of multi-component complexes
in vivo.
In conclusion, this work provides the first evidence for NlpI as a
novel adaptor of EPases (and possibly other classes of PG hydro-
lases) and we hypothesize that NlpI acts as a scaffolding protein to
facilitate the formation of complexes between PG synthases and
EPases (Fig 6B).
Materials and Methods
Media and growth conditions
Strains used in this work were grown in LB medium (1% tryptone,
1% NaCl, 0.5% yeast extract) at 37°C, unless otherwise stated.
Antibiotics were used at the following concentrations (lg/ml):
ampicillin (Amp), 100; chloramphenicol (Cam), 25; kanamycin
(Kan), 50. MC4100 cells were grown to steady state (Vischer et al,
2015) in glucose minimal medium containing 6.33 g of
K2HPO4.3H2O, 2.95 g of KH2PO4, 1.05 g of (NH4)2, 0.10 g of
MgSO4.7H2O, 0.28 mg of FeSO4.7H2O, 7.1 mg of Ca(NO3)2.4H2O,
4 mg of thiamine and 4 g of glucose. For strain MC4100, 50 lg
lysine per liter was added. Absorbance was measured at 450 nm
with a 300-T-1 spectrophotometer (Gilford Instrument Laboratories
Inc.). A list of all strains and plasmids used in this study can be
found in Appendix Tables S1 and S2, respectively.
Bacterial strain construction
BW25113 was used as the parent strain (WT) for this study unless
otherwise stated. Strains were generated, by transducing P1 lysates
derived from the corresponding deletion strains of the Keio and
Aska strain collections (Adams & Luria, 1958; Baba et al, 2006). A
list of all primers used in this study can be found in
Appendix Table S3.
Generation of the NlpI-HA-tagged strain
For HA-tagging, pKD13 (kanamycin resistant) was used as a PCR
template. The kanamycin cassette was amplified by PCR with the
primers 74-NlpI-HA-O1 and 87-NlpI-HA-O2. The primer 74-NlpI-HA-
O1 was carrying from 50 to 30: the homology region of the C-terminal
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of NlpI (without the STOP codon), 2 HA-tag and the homology
region of the N-terminus of the kanamycin cassette (from the
pKD13). The primer 87-NlpI-HA-O2 was carrying from 50 to 30 the
homology region of the downstream region of NlpI and the homol-
ogy region of the C-terminus of the kanamycin cassette.
Generation of the NlpI-Strep-Flag (-SF) tagged strain
For SF-tagging, pJSP1 (containing the SF-tag and a kanamycin
cassette) was used as a PCR template. The SF-tag and kanamycin
cassette were amplified by PCR with the primers 175-NlpI-SF-O1
and 176-NlpI-SF-O2. The primer 175-NlpI-SF-O1 was carrying from
50 to 30 the homology region of the C-terminal of NlpI (without the
stop codon) and the homology region of the N-terminal of the Strep-
Flag tag (from the pJSP1). The primer 176-NlpI-SF-O2 was carrying
from 50 to 30 the homology region of the downstream region of NlpI
and the homology region of the C-terminus of the kanamycin
cassette.
Transformation and antibiotic resistance selection were
performed as previously described (Datsenko & Wanner, 2000).
BW25113 transformants carrying a Red helper plasmid were grown
in 5-ml SOB cultures with ampicillin and L-arabinose at 30°C to an
OD600 of 0.6 and then made electrocompetent by concentrating
100-fold and washing three times with ice-cold 10% glycerol. PCR
products were gel-purified, digested with DpnI, re-purified and
suspended in elution buffer (10 mM Tris, pH 8.0). Electroporation
was done by using a Cell-Porator with a voltage booster and 0.15-
cm chambers according to the manufacturer’s instructions (GIBCO/
BRL) by using 25 ll of cells and 10–100 ng of PCR product. Shocked
cells were added to 1 ml SOC and incubated 1 h at 37°C, and then,
one-half of the incubation/cells were spread onto agar to select KmR
transformants.
Eliminating antibiotic resistance gene for the NlpI-HA
Antibiotic resistance was eliminated as described (Datsenko &
Wanner, 2000). The pCP20 plasmid has ampicillin and chloram-
phenicol resistance genes and shows temperature-sensitive replica-
tion and thermal induction of FLP synthesis (Cherepanov &
Wackernagel, 1995). KmR mutants were transformed with pCP20,
and ampicillin-resistant transformants were selected at 30°C, after
which a few were colony-purified once non-selectively at 43°C and
then tested for loss of all antibiotic resistances. The majority of the
mutants lost the FRT-flanked resistance gene and the FLP helper
plasmid simultaneously.
Immunolabelling
The specificity of the antibody was confirmed by labelling a WT and
DnlpI strain with affinity-purified anti-NlpI. Quantitative analysis of
the fluorescence found in the DnlpI strain gave the same level as
WT cells immunolabelled with secondary antibodies only, whereas
the WT cells showed a much higher fluorescence level with the puri-
fied anti-NlpI and a regular distribution of foci in the envelope.
After reaching steady state, the cells were fixed for 15 min by
addition of a mixture of formaldehyde (f.c. 2.8%) and glutaralde-
hyde (f.c. 0.04%) to the shaking water bath and immunolabelled as
described (Buddelmeijer et al, 2013) with rabbit polyclonal
antibodies against NlpI or against the HA-tag. As secondary anti-
body, donkey anti-rabbit conjugated to Cy3 or conjugated to Alex-
a488 (Jackson Immunochemistry, USA) diluted 1:300 in blocking
buffer (0.5% (wt/vol) blocking reagents (Boehringer, Mannheim,
Germany) in PBS) was used, and the samples were incubated for
30 min at 37°C. For immunolocalization, cells were immobilized on
1% agarose in water slabs coated object glasses as described (Kop-
pelman et al, 2004) and photographed with an Orca Flash 4.0
(Hamamatsu) CCD camera mounted on an Olympus BX-60 fluores-
cence microscope through a 100×/N.A. 1.35 oil objective. Images
were taken using the program ImageJ with MicroManager (https://
www.micro-manager.org).
SIM images were obtained with a Nikon Ti Eclipse microscope
and captured using a Hamamatsu Orca-Flash 4.0 LT camera. Phase-
contrast images were acquired with a Plan APO 100×/1.45 Ph3 oil
objective. SIM images were obtained with a SR APO TIRF 100×/1.49
oil objective, using 3D-SIM illumination with a 488 nm laser, and
were reconstructed with Nikon-SIM software using the values 0.23–
0.75–0.10 for the parameters Illumination Modulation Contrast
(IMC), High Resolution Noise Suppression (HNS) and Out of focus
Blur Suppression (OBS).
Image analysis
Phase-contrast and fluorescence images were combined into hyper-
stacks using ImageJ (http://imagej.nih.gov/ij/), and these were
linked to the project file of Coli-Inspector running in combination
with the plugin ObjectJ (https://sils.fnwi.uva.nl/bcb/objectj/). The
images were scaled to 15.28 pixels per lm. The fluorescence back-
ground has been subtracted using the modal values from the fluo-
rescence images before analysis. Slight misalignment of
fluorescence with respect to the cell contours as found in phase
contrast was corrected using Fast-Fourier techniques as described in
Vischer et al (2015). Data analysis was performed as described in
Vischer et al (2015). In brief, midcell was defined as the central part
of the cell comprising 0.8 lm of the axis. From either cell part,
midcell or remaining cell, the volume, the integrated fluorescence,
and, thus, the concentration of fluorophores were calculated. The
difference of the two concentrations is multiplied with the volume
of midcell. It yields FCPlus (surplus of fluorescence). For age
calculation, all cell lengths are sorted in ascending order. Then the
equation:
age ¼ lnð1 0:5  rank=ðnCells 1ÞÞ= lnð0:5Þ
is used, where rank is a cell’s index in the sorted array, nCells is
the total amount of cells, and age is the cell’s age expressed in the
range 0–1.
Ni2+-NTA pull-down assay
His-tagged proteins of interest were incubated with untagged or
native ligands, in the presence of Ni2+-NTA-coupled agarose beads
(Qiagen). Beads were pre-equilibrated with dH2O and binding buffer
(10 mM HEPES/NaOH, 10 mM MgCl2, 150 mM, NaCl 0.05% Triton
X-100, pH 7.5) by centrifugation at 4,000 g, 4 min at 4°C. Samples
were incubated overnight on a spinning plate at 4°C before beads
were washed 3–6 times with 10 mM HEPES/NaOH, 10 mM MgCl2,
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150 mM, NaCl 0.05% Triton X-100, 30 mM imidazole, pH 7.5.
Retained material was eluted from Ni2+-NTA beads using proteus
spin columns and boiling at 100°C in SDS-buffer (50 mM Tris–HCl
pH 6.8, 2% SDS, 10% glycerol 0.02% bromophenol blue, 10% b-
mercaptoethanol). Elutions were diluted 1:1 with dH2O, and
proteins were separated by SDS–PAGE for analysis.
Protein overexpression and purification
Prior to purification, plasmids of interest were transformed into
E. coli strain BL21 (kDE3) and grown overnight in LB agar (1.5%
w/v) containing appropriate antibiotic, at 37°C. Transformants were
inoculated into 50 ml of LB with appropriate antibiotic and grown
overnight at 37°C, shaking. Pre-cultures were diluted 1:40 in 2 l LB
and grown to OD578 0.5–0.6, at 37°C. Induction conditions are speci-
fied for each respective protein below. After overexpression, cells
were harvested by centrifugation at 7,500 g, 15 min, 4°C. Pellets
were re-suspended in buffer I (25 mM Tris–HCl, 300 mM NaCl, pH
7.5) with the addition of a small amount of DNase (Sigma) and
100 lM P.I.C and PMSF. Cells were lysed by sonication (Branson
digital) and the lysate was centrifuged at 14,000 g, 1 h, 4°C, before
the supernatant was applied at 1 ml/min to a 5 ml chromatography
column attached to an A¨KTA Prime plus (GE Healthcare).
If desired, the removal of his-tags for tagged constructs, follow-
ing immobilized metal affinity chromatography steps, was achieved
by incubating protein samples with 1 unit/ml of restriction grade
thrombin (Novagen). This was carried out overnight at 4°C in
25 mM Tris–HCl, 200 mM NaCl, pH 8.0 or 25 mM HEPES/NaOH,
300 mM NaCl, 10% glycerol, pH 7.5, depending on the next purifi-
cation step. Removal of His-tag was verified by Western blot with
monoclonal a-His–HRP (1:10000) antibody (Sigma).
Purification of MepM
MepM was purified as previously described in More´ et al (2019).
Purification of MepS and MepS(C68A)
MepS and MepSC68A (MepS*) overexpression was induced with
1 mM IPTG for 90 min at 37°C. Following harvesting, lysate was
applied to a 5 ml HisTrap HP column (GE Healthcare) in buffer
containing 25 mM Tris–HCl, 300 mM NaCl, 20 mM imidazole pH
7.5. Protein was eluted in 25 mM Tris–HCl, 300 mM NaCl, 400 mM
imidazole, 10% glycerol, pH 7.5. Protein purity and yield were anal-
ysed by SDS–PAGE, and the fractions of interest were pooled and
dialysed overnight against 25 mM HEPES/NaOH, 300 mM NaCl,
10% glycerol, pH 7.5. Protein was concentrated to ~5 ml using
Vivaspin concentrator spin columns (Sartorius) at 4,500 g, 4°C and
applied to a HiLoad 16/600 Superdex 200 column (GE Healthcare)
at 1 ml/min. Protein purity and yield were analysed by SDS–PAGE,
and the best fractions were pooled and stored at 80°C. Disclaimer:
The authors note that the purification of an “active” preparation of
MepS from pET21b-MepS-His (Singh et al, 2012) was difficult and
irreproducible. We were not able to purify an “active” version of
MepS to show activity against muropeptides on its own; however,
we were able to consistently detect low levels of activity in the pres-
ence of NlpI. We addressed NlpI stimulation using this “active”
preparation of MepS in the manuscript. However, subsequent
purifications of MepS were not always consistent in showing this
stimulation by NlpI.
Purification of NlpI
NlpI overexpression was induced with 1 mM IPTG, 3 h at 30°C, before
harvesting of cells as described above. Following harvesting, lysate
was applied to a 5 ml HisTrap HP column (GE Healthcare) and
washed with buffer containing 25 mM Tris–HCl, 300 mM NaCl,
20 mM imidazole pH 7.5. Protein was eluted in 25 mM Tris–HCl,
300 mM NaCl, 400 mM imidazole, 10% glycerol, pH 7.5. Protein
purity and yield were analysed by SDS–PAGE, and the fractions of
interest were pooled and dialysed overnight against 25 mM HEPES/
NaOH, 200 mM NaCl, 10% glycerol, pH 7.5. Protein was concentrated
to ~ 5 ml using Vivaspin concentrator spin columns (Sartorius) at
4,500 g, 4°C and applied to a HiLoad 16/600 Superdex 200 column
(GE Healthcare) at 1 ml/min. Protein purity and yield were analysed
by SDS–PAGE, and the best fractions were pooled and stored
at80°C.
Purification of PBP4
Purification of native PBP4 followed an adapted protocol from Kishida
et al (2006). PBP4 overexpression was induced with 1 mM IPTG for
8 h at 20°C and then harvested by centrifugation at 7,500 g, 4°C,
15 min. Cell pellets were re-suspended in buffer (50 mM Tris–HCl,
300 mM NaCl, pH 8.0) and lysed by sonication before centrifuging at
14,000 g, 1 h, 4°C and reducing NaCl concentration by stepwise dialy-
sis in a Spectra/Por dialysis membrane (MWCO 12–14 kDa). Cell
supernatant was first dialysed against dialysis buffer I (50 mM Tris–
HCl, 200 mM NaCl, pH 8.5) for 1 h at 4°C, then against dialysis buffer
II (50 mM Tris–HCl, 100 mM NaCl, pH 8.5) for 1 h at 4°C and then
finally against dialysis buffer III (50 mM Tris–HCl, 30 mM NaCl, pH
8.5), O/N at 4°C. Dialysed protein sample was then centrifuged at
7,500 g, 4°C, 10 min, and supernatant applied to a 5 ml HiTrap Q HP
IEX column in 25 mM Tris–HCl, 30 mM NaCl, pH 8.5. Protein was
eluted from the column with a linear gradient of buffer 2 containing
25 mM Tris–HCl, 1 M NaCl, pH 8.0, over a 100 ml volume. Fractions
of interest were analysed by SDS–PAGE, and the best fractions were
pooled and dialysed O/N, at 4°C, against dialysis buffer containing
10 mM potassium phosphate, 300 mM NaCl, pH 6.8. Protein was
applied at 1 ml/min to a 5 ml ceramic hydroxyapatite column (Bio-
Rad BioscaleTM) in the dialysis buffer. Fractionation of proteins was
achieved by using a linear gradient of buffer 2 (500 mM potassium
phosphate, 300 mM NaCl, pH 6.8) over a 50-ml gradient. Fractions of
highest purity and yield were dialysed overnight against 25 mM
HEPES/NaOH, 300 mM NaCl, 10% glycerol, pH 7.5 and concentrated
to ~ 5 ml using Vivaspin concentrator spin columns (Sartorius).
Protein sample was applied to a HiLoad 16/600 Superdex 200 column
(GE Healthcare) at 1 ml/min pre-equilibrated with dH2O and buffer I
(25 mM HEPES/NaOH, 300 mM NaCl, 10% glycerol, pH 7.5). Samples
were analysed by SDS–PAGE, and fractions containing purified protein
were pooled and stored at80°C.
Purification of PBP7
PBP7 overproduction was induced with 1 mM IPTG for 3 h at 30°C
before being harvested by centrifugation as described above and re-
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suspended in buffer I (25 mM Tris–HCl, 500 mM NaCl, 20 mM imida-
zole, pH 7.5). Following sonication and subsequent centrifugation as
described above, the lysate was applied to a 5 ml HisTrap HP column
(GE Healthcare) and washed with four column volumes of buffer I;
before bound protein was eluted with buffer II (25 mM Tris–HCl,
300 mM NaCl, 400 mM imidazole pH 7.5). Samples were analysed by
SDS–PAGE and dialysed overnight against 25 mM HEPES/NaOH,
300 mM NaCl, 10% glycerol, pH 7.5, before being concentrated to
~5 ml using Vivaspin concentrator spin columns (Sartorius) at
4,500 g, 4°C. Protein samples were applied to a HiLoad 16/600
Superdex 200 column (GE Healthcare) at 1 ml/min pre-equilibrated
with dH2O and buffer I (25 mM HEPES/NaOH, 300 mM NaCl, 10%
glycerol, pH 7.5). Samples were analysed by SDS–PAGE, and the
purest fractions with highest yield were pooled and stored at80°C.
Purification of PBP1A and LpoA
Purification of PBP1A and LpoA was as described previously in Born
et al (2006) and Jean et al (2014), respectively.
Microscale Thermophoresis assays
NlpI, MepS, PBP1A, PBP4 and PBP7 were labelled on amines with
NT647 RED-N-hydroxysuccinimide (NHS) reactive dye, whilst LpoA
was labelled on cysteines with NT647 RED-Maleimide reactive dye
(Nanotemper) according to manufacturer’s instructions (Nanotem-
per) and as described in Jerabek-Willemsen et al (2011).
Two-fold serial dilution of proteins was done in MST buffer
containing 25 mM HEPES/NaOH, 150 mM NaCl, 0.05% Triton X-
100, pH 7.5. Unlabelled ligands were titrated from the following
starting concentrations: NlpI (50 lM), MepM (30 lM), MepS(C68A)
(30 lM), PBP4 (50 lM), PBP7 (30 lM) and LpoA (30 lM). Ligands
were serially diluted 16 times and assayed for interactions with
labelled proteins of interest at 10–40% MST power in standard or
premium capillaries on a Monolith NT.115. Binding curves and
kinetic parameters were plotted and estimated using NT Analysis
1.5.41 and MO. Affinity Analysis (x64) software.
SDS Denaturation (SD) test
Prior to all MST measurements, capillary scans were carried out to
check for consistent initial fluorescence counts. In assays that
showed concentration-dependent changes in fluorescence intensity,
SDS denaturation tests were carried out to investigate whether
changes were non-specific or were a property of ligand binding.
10 ll from samples containing the highest and lowest concentration
of unlabelled ligand was centrifuged 10,000 g, 5 min, RT and mixed
1:1 volume ratio with SD-test buffer (40 mM DTT, 4% SDS).
Mixtures were boiled at 100°C for 10 min to abolish ligand binding
before being spun down and subjected to another capillary scan. If
fluorescence intensities were back to within the margin of error,
then initial changes were due to ligand binding and binding curves
were plotted using raw fluorescence values.
Fixed ligand concentration MST assays for trimeric complexes
For fixed ligand concentration MST assays, labelled proteins were
titrated against a fixed concentration of unlabelled proteins,
respectively. In fixed concentration assays with labelled MepS or
LpoA, unlabelled PBP4-NlpI or PBP7-NlpI complexes were pre-
formed by incubating NlpI (3 lM) with excess PBP4 or PBP7
(30 lM), on ice for 10 min. In fixed concentration assays with
labelled PBP1A, unlabelled PBP4-NlpI complex was pre-formed by
incubating PBP4 (0.5 lM) with NlpI (1 lM), on ice for 10 min.
Thermophoresis or fluorescence of labelled protein in the presence
of unlabelled ligands was determined using NT Analysis 1.5.41 and
MO Affinity Analysis (×64) software.
Analytical ultracentrifugation
Purified NlpI was dialysed O/N against 25 mM HEPES/NaOH,
150 mM NaCl, pH 7.5, in preparation for AUC. AUC sedimentation
velocity (SV) experiments were carried out in a Beckman Coulter
(Palo Alto, CA, USA) ProteomeLab XL-I analytical ultracentrifuge
using absorbance at 280 nm and interference optics. All AUC runs
were carried out at a rotation speed of 45,000 rpm at 20°C using an
8-hole AnTi50 rotor and double-sector aluminium-Epon centre-
pieces. The sample volume was 400 ll and the sample concentra-
tions ranged between 0.3 and 1.2 mg/ml. The partial specific
volumes (v) for the proteins were calculated from the amino acid
sequence of NlpI, using the program SEDNTERP (Laue et al, 1992).
Sedimentation velocity profiles were treated using the size-distribu-
tion c(s) model implemented in the program SEDFIT14.1 (Schuck,
2000). The experimental values of the sedimentation coefficient
were corrected for the viscosity and density of the solvent, relative
to that of H2O at 20°C (s20,w). The atomic coordinates from the
published crystal structure of (Wilson et al, 2005) were used to
calculate the sedimentation coefficient values for the monomer and
dimer of NlpI using the program SoMo (Brookes et al, 2010).
In vitro PG digestion assays
PG digestion assays and subsequent muropeptide composition
analysis were carried out as previously described (Glauner, 1988).
10% (v/v) substrate isolated from E. coli strain MC1061 was
utilized in digestion reactions as follows: MepM (2 lM)  NlpI
(4 lM) incubated against intact sacculi for 4 h, MepS
(5 lM)  NlpI (10 lM) incubated against muropeptides O/N,
PBP4 (2 lM)  NlpI (4 lM) incubated against sacculi for 4 h,
PBP7 (2 lM)  NlpI (4 lM) incubated against muropeptides for
4 h. Standard reaction conditions were 10 mM HEPES/NaOH,
10 mM MgCl2, 150 mM NaCl, 0.05% Triton X-100, pH 7.5, in
100 ll reaction volume. Following incubation, samples were boiled
at 100°C, 10 min, to terminate reactions before digesting remaining
PG overnight at 37°C, with 1 lM cellosyl (Hoechst, Frankfurt am
Main, Germany). The samples were centrifuged at 10,000 g for
5 min, RT, to obtain digested muropeptide products in the super-
natant. Following digestion, muropeptide products were reduced
with NaBH4, adjusted to pH 4–5 and separated for analysis by
reversed-phase HPLC (Glauner, 1988).
Pre-digested muropeptides were obtained by incubating intact
sacculi from E. coli strain MC1061, with 1 lM cellosyl at 37°C, over-
night. Following this, reactions were terminated by boiling at 100°C
for 5 min and the muropeptide substrates obtained by centrifugation
at 10,000 g for 5 min, RT and taking the supernatant. Reactions
were then carried out and prepared for analysis as described above.
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Continuous fluorescence glycosyltransferase (GTase) assay
Dansylated lipid II was prepared as previously published (Breukink
et al, 2003). Continuous fluorescence GTase assays were performed
as described (Banzhaf et al, 2012), using PBP1A (final concentration
0.5 lM), LpoA (1 lM), of MepSC68A (MepS*) (2 lM) and of NlpI
(4 lM), in 50 mM HEPES/NaOH pH 7.5, 150 mM NaCl, 25 mM
MgCl2, 0.05% Triton X-100. Briefly, dansylated lipid II was added to
start the reactions and the decrease in fluorescence was measured
over time at 30°C using a plate reader (excitation wavelength of
330 nm, emission of 520 nm).
PG GTase activity assay
Substrate was prepared for the assay as follows: 0.5 lM ATTO647-
labelled lipid II was mixed with 25 lM unlabelled lipid II in 1:1
chloroform-methanol. The mixture was dried and re-suspended in
0.2% Triton X-100. Reactions were carried out in the presence of
1 mM ampicillin in 10 mM HEPES/NaOH, 10 mM MgCl2, pH 7.5,
150 mM NaCl, 0.05% Triton X-100. Samples were incubated for 1 h
at 37°C and boiled at 100°C for 5 min, to terminate reactions.
Samples (15 ll) were dried in a vacuum concentrator before being
re-dissolved in 4 ll of loading buffer (60 mM Tris–HCl, pH 8.8, 25%
glycerol, 2% SDS + bromophenol blue). Glycan chain products were
analysed by Tris-Tricine SDS–PAGE (Meeske et al, 2016; Egan et al,
2018).
Measurement of TPase activity using radiolabelled lipid II
Measurement of TPase activity using [14C]GlcNAc-labelled lipid II
substrate was carried out as previously described (Bertsche et al,
2005). Lipid II stored in chloroform/methanol (1.2 nM) was vacuum
dried in glass tubes and re-suspended in 5 ll 0.2% Triton X-100.
The reactions were carried out using PBP1A (0.5 lM), LpoAsol
(1 lM), MepS* (2 lM), NlpIsol (4 lM), as required, in 10 mM
HEPES/NaOH, 100 mM MgCl2, 150 mM NaCl, 0.05% Triton X-100
in a final volume of 100 ll. Reactions were initiated by adding the
reaction mixtures to the substrate and then incubating at 37°C for
1.5 h with shaking. Reactions were terminated by boiling at 100°C
for 10 min, before samples were adjusted to pH 4.8 and incubated
with ~1 lM cellosyl (Hoechst, Germany) for a further 1.5 h at 37°C.
Samples were then boiled at 100°C for 10 min and muropeptides
reduced with NaBH4 (in 0.5 M sodium borate buffer), prior to HPLC
analysis as described in Glauner (1988).
Purification of anti-NlpI
This protocol was adapted from a previously published method
(Banzhaf et al, 2012). Serum against NlpI was obtained from rabbits
at Eurogentec (Herstal, Belgium), using purified oligohistidine-
tagged NlpI protein for immunization. For affinity purification of the
serum, purified His-NlpI (5 mg) was coupled to 0.45 g of CNBr-acti-
vated sepharose (GE) following the manufacturers protocol. The
column was washed with 30 ml of wash buffer I (10 mM Tris–HCl,
1 M NaCl, 10 mM MgCl2, 0.1% Triton X-100, pH 7.2), 5 ml of
elution buffer I (100 mM Glycine/HCl, 0.1% Triton X-100 pH 2.0)
and equilibrated with 30 ml of block buffer (200 mM Tris–HCl,
500 mM NaCl, 0.1% Triton X-100 pH 8.0). Rabbit serum (10 ml)
was mixed with 35 ml of serum buffer (10 mM Tris–HCl pH 7.4)
and adjusted to a total concentration of 0.1% of Triton X-100. The
solution was centrifuged (4,000 g, 45 min, 4°C), and the super-
natant was applied to the CNBr-activated sepharose His-PBP2
column using a peristaltic pump with constant slow flow for 48 h.
The column was washed with 30 ml of wash buffer I and with
20 ml of wash buffer II (10 mM Tris–HCl, 150 mM NaCl, 10 mM
MgCl2, 0.1% Triton X-100, pH 7.2). The NlpI antibodies were eluted
with 10 ml of elution buffer I and mixed with 2 ml of elution buffer
II (2 M Tris–HCl, pH 8.0) afterwards. The elution was analysed by
SDS–PAGE, and glycerol was added to a final concentration of 20%
and the purified PBP2 antibodies were stored at 20°C. Anti-NlpI
was tested for specificity by Western blot (Appendix Fig S5C).
Preparation of membrane fraction for affinity chromatography
This protocol was adapted from a previously published method
(Vollmer et al, 1999). Membranes were isolated from 4 l of E. coli
BW25133 grown at 37°C to an optical density (578 nm) of 0.7. Cells
were harvested at (5,000 g, 10 min, 4°C), re-suspended in 20 ml of
MF buffer I (10 mM Tris/maleate, 10 mM MgCl2, pH 6.8) and
disrupted by sonication, with a Branson Digital Sonifier operating at
50 W for 5 min. Membranes were sedimented by ultracentrifugation
(80,000 g, 60 min, 4°C). The pellet was re-suspended in 20 ml of
MF buffer II (10 mM Tris–maleate, 10 mM MgCl2, 1 M NaCl, 2%
Triton X-100, pH 6.8) to extract all membrane proteins by stirring
overnight at 4°C. The supernatant obtained after another ultracen-
trifugation step (80,000 g, 60 min, 4°C) was diluted by the addition
of 20 ml of MF dialysis buffer I (10 mM Tris/maleate, 10 mM
MgCl2, 50 mM NaCl, pH 6.8) and dialysed against 5 l of the same
buffer. The obtained membrane fraction was used directly for affin-
ity chromatography. For high salt affinity chromatography, the
obtained membrane fraction was dialysed against 3 l of MF buffer
III (10 mM Tris/maleate, 10 mM MgCl2, 400 mM NaCl, pH 6.8). For
membrane extracts using the detergent DDM, Triton X-100 was
replaced with 1% DDM.
Affinity chromatography
This protocol was adapted from a previously published method
(Vollmer et al, 1999). Sepharose beads were activated following the
instructions of the manufacturer (GE). Coupling of 2 mg of protein
to 0.13 g of activated sepharose beads was carried out overnight at
6°C with gentle agitation in protein buffer. After washing the beads
with protein buffer, the remaining coupling sites were blocked by
incubation in AC blocking buffer (200 mM Tris–HCl, 10 mM MgCl2,
500 mM NaCl, 10% glycerol and 0.25% Triton X-100, pH 7.4) with
gentle agitation overnight at 6°C. The beads were washed alternat-
ingly with AC blocking buffer and AC acetate buffer (100 mM
sodium acetate, 10 mM MgCl2, 500 mM NaCl, 10% glycerol and
0.25% Triton X-100, pH 4.8) and finally re-suspended in AC buffer I
(10 mM Tris/maleate, 10 mM MgCl2, 50 mM NaCl, 1% Triton X-
100, pH 6.8). As control (Tris-Sepharose), one batch of activated
Sepharose beads was treated identically with the exception that no
protein was added. Affinity chromatography was performed at 6°C.
E. coli membrane fraction extracted out of 2 l per sample (see
above) containing 50 mM NaCl (or 400 mM NaCl for high salt chro-
matography) was incubated with gentle agitation overnight. The
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column was washed with 10 ml of AC wash buffer (10 mM Tris/
maleate, 10 mM MgCl2, 50 mM NaCl and 0.05% Triton X-100, pH
6.8). Retained proteins were eluted with 20 ml of AC elution buffer I
(10 mM Tris/maleate, 10 mM MgCl2, 150 mM NaCl, 0.05% Triton
X-100, pH 6.8) followed by a second elution step with 1 ml of AC
elution buffer II (10 mM Tris/maleate, 10 mM MgCl2, 1 M NaCl,
0.05% Triton X-100, pH 6.8). Both elution fractions were stored at
20°C. For the high salt affinity chromatography, the AC high salt
wash buffer (10 mM Tris/maleate, 10 mM MgCl2, 400 mM NaCl
and 0.05% Triton X-100, pH 6.8) and the AC high salt elution buffer
(10 mM Tris/maleate, 10 mM MgCl2, 2 M NaCl, 0.05% Triton X-
100, pH 6.8) were used. Elutions were analysed by liquid chro-
matography (LC)-MS/MS.
Mass spectrometry to identify NlpI affinity chromatography hits
For liquid chromatography (LC)-MS/MS, tryptic peptides were
desalted (Oasis HLB lElution Plate, Waters), dried in vacuum and
reconstituted in 20 ll of 4% acetonitrile, 0.1% formic acid. In total,
1 lg of peptide was separated with a nanoACQUITY UPLC system
(Waters) fitted with a trapping column (nanoAcquity Symmetry C18;
5 lm [average particle diameter]; 180 lm [inner diame-
ter] × 20 mm [length]) and an analytical column (nanoAcquity BEH
C18; 1.7 lm [average particle diameter]; 75 lm [inner diame-
ter] × 200 mm [length]). Peptides were separated on a 240-min
gradient and were analysed by electrospray ionization–tandem mass
spectrometry on an Orbitrap Velos Pro (Thermo Fisher Scientific).
Full-scan spectra from a mass/charge ratio of 300 to one of 1,700 at
a resolution of 30,000 full widths at half maximum were acquired in
the Orbitrap mass spectrometer. From each full-scan spectrum, the
15 ions with the highest intensity were selected for fragmentation in
the ion trap. A lock-mass correction with a background ion (mass/
charge ratio, 445.12003) was applied.
The raw mass spectrometry data were processed with MaxQuant
(v1.5.2.8; Cox & Mann, 2008) and searched against an Uniprot E. coli
K12 proteome database. The search parameters were as following:
carbamidomethyl (C) (fixed), acetyl (N-term) and oxidation (M)
(variable) were used as modifications. For the full-scan MS spectra
(MS1), the mass error tolerance was set to 20 ppm and for the
MS/MS spectra (MS2) to 0.5 Da. Trypsin was selected as protease
with a maximum of two missed cleavages. For protein identification,
a minimum of one unique peptide with a peptide length of at least
seven amino acids and a false discovery rate below 0.01 were
required on the peptide and protein level. The match between runs
function was enabled, and a time window of one minute was set.
Label-free quantification was selected using iBAQ (calculated as the
sum of the intensities of the identified peptides and divided by the
number of observable peptides of a protein) (Schwanhausser et al,
2011), with the log fit function enabled.
The proteinGroups.txt file, an output of MaxQuant, was loaded
into R (ISBN 3-900051-07-0) for further analysis. The iBAQ values of
the MaxQuant output were first batch-corrected using the limma
package (Ritchie et al, 2015) and then normalized with the vsn
package (Huber et al, 2002). Individual normalization coefficients
were estimated for each biological condition separately. Limma was
used again to test the normalized data for differential expression.
Proteins were classified as a “hit” with a log2 fold change higher
than 4 and a “candidate” with a log2 fold change higher than 2.
Genetic interaction assay
For quantitation of genetic interactions, strains were grown to late
exponential phase (~0.7 OD578), adjusted to an OD578 of 1 and spread
out using glass beads on rectangular LB Lennox plates (200 ll per
strain per plate). Plates were dried at 37°C for one hour and before
they were used as a source plate for the genetic interaction assay. One
source plate for each strain was arrayed using a Rotor HDA replicator
on Lennox LB agar plates to transfer 96 clones to the genetic interac-
tion plate. On each genetic interaction assay plate, the parental strain,
the single deletion A, the single deletion B and the double deletion AB
(or BA) were arrayed, each in 96 copies per plate. Plates were incu-
bated at 37°C for 12 h and imaged under controlled lighting condi-
tions (spImager S&P Robotics) using an 18 megapixel Canon Rebel
T3i (Canon). Colony integral opacity as fitness readout was quantified
using the image analysis software Iris (Kritikos et al, 2017). Double-
mutant genetic interaction scores were calculated as previously
described. Briefly, fitness ratios are calculated for all mutants by divid-
ing their fitness values by the respective WT fitness value. The
product of single mutant fitness ratios (expected) is compared to the
double mutant fitness ratio (observed) across replicates. The probabil-
ity that the two means (expected and observed) are equal across repli-
cates is obtained by a Student’s two-sample t-test.
Thermal proteome profiling and sample preparation
Thermal proteome profiling was performed as previously described
in Mateus et al (2018). Briefly, bacterial cells were grown overnight
at 37°C in lysogeny broth and diluted 100-fold into 20 ml of fresh
medium. Cultures were grown aerobically at 37°C with shaking
until optical density at 578 nm (OD578) ~0.5. Cells were then
pelleted at 4,000 g for 5 min, washed with 10 ml PBS, re-suspended
in the same buffer to an OD578 of 10 and aliquoted to a PCR plate.
The plate was subjected to a temperature gradient for 3 min in a
PCR machine (Agilent SureCycler 8800), followed by 3 min at room
temperature. Cells were lysed with lysis buffer (final concentration:
50 lg/ml lysozyme, 0.8% NP-40, 1× protease inhibitor (Roche),
250 U/ml benzonase and 1 mM MgCl2 in PBS) for 20 min, shaking
at room temperature, followed by three freeze–thaw cycles. Protein
aggregates were then removed, and the soluble fraction was
digested according to a modified SP3 protocol (Mateus et al, 2018).
Peptides were labelled with TMT6plex (Thermo Fisher Scientific),
desalted with solid-phase extraction on a Waters OASIS HLB lElu-
tion Plate (30 lm) and fractionated onto six fractions on a reversed-
phase C18 system running under high pH conditions.
2D-TPP mass spectrometry-based proteomics
Samples were analysed with liquid chromatography coupled to
tandem mass spectrometry, as previously described (Mateus et al,
2018). Briefly, peptides were separated using an UltiMate 3000 RSLC
nano-LC system (Thermo Fisher Scientific) equipped with a trapping
cartridge (Precolumn C18 PepMap 100, 5 lm, 300 lm i.d. × 5 mm,
100 A˚) and an analytical column (Waters nanoEase HSS C18 T3,
75 lm × 25 cm, 1.8 lm, 100 A˚). Solvent A was 0.1% formic acid in
LC-MS grade water, and solvent B was 0.1% formic acid in LC-MS
grade acetonitrile. After loading the peptides onto the trapping
cartridge (30 ll/min of solvent A for 3 min), elution was performed
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with a constant flow of 0.3 ll/min using a 60–120 min analysis time
(with a 2–28% B elution, followed by an increase to 40% B, and re-
equilibration to initial conditions). The LC system was directly
coupled to a Q Exactive Plus mass spectrometer (Thermo Fisher
Scientific) using a Nanospray-Flex ion source and a Pico-Tip Emitter
360 lm OD × 20 lm ID; 10 lm tip (New Objective). The mass spec-
trometer was operated in positive ion mode with a spray voltage of
2.3 kV and capillary temperature of 320°C. Full-scan MS spectra
with a mass range of 375–1,200 m/z were acquired in profile mode
using a resolution of 70,000 (maximum fill time of 250 ms or a
maximum of 3e6 ions (automatic gain control, AGC)). Fragmenta-
tion was triggered for the top 10 peaks with charge 2–4 on the MS
scan (data-dependent acquisition) with a 30-s dynamic exclusion
window (normalized collision energy was 32), and MS/MS spectra
were acquired in profile mode with a resolution of 35,000 (maxi-
mum fill time of 120 ms or an AGC target of 2e5 ions).
2D-TT data analysis
Protein identification and quantification
Mass spectrometry data were processed as previously described
(Mateus et al, 2018). Briefly, raw mass spectrometry files were
processed with IsobarQuant (Franken et al, 2015) and peptide and
protein identification were performed with Mascot 2.4 (Matrix
Science) against the E. coli (strain K12) Uniprot FASTA (Proteome
ID: UP000000625), modified to include known contaminants and
the reversed protein sequences (search parameters: trypsin; missed
cleavages 3; peptide tolerance 10 ppm; MS/MS tolerance 0.02 Da;
fixed modifications were carbamidomethyl on cysteines and TMT10-
plex on lysine; variable modifications included acetylation on
protein N-terminus, oxidation of methionine and TMT10plex on
peptide N-termini).
Thermal proteome profiling analysis
Data analysis was performed in R, as previously described in Mateus
et al (2018). Briefly, all output data from IsobarQuant were normalized
using variance stabilization (vsn) (Huber et al, 2002). Abundance and
stability scores were calculated with a bootstrap algorithm (Becher
et al, 2018), together with a local FDR that describes the quality and
the reproducibility of the score values (by taking into account the vari-
ance between replicates). A local FDR < 0.05 and a minimum absolute
score of 10 were set as thresholds for significance. Abundance and
stability scores of knocked out genes were discarded.
CPRG assay
The CPRG assay was performed as described in Paradis-Bleau et al
(2014). Strains were transformed with the plasmid pCB112 encoding
b-galactosidase (LacZ) and grown for 16 h on CPRG medium LB
[75 mM NaCl agar supplemented with CPRG (20 lg/ml), chloram-
phenicol (20 lg/ml) and IPTG (50 lM)] prior taking an end-point
picture. CPRG (yellow) conversion to CPR (red) indicates impaired
envelope integrity.
MepS Western blot
Concerning the MepS polyclonal antibody used the Western blot,
the peptide CMGKSVSRSNLRTGD, corresponding to the amino acids
120–133 of MepS, was synthetized by Proteogenix (Schiltigheim,
France) and used for immunization and primary antibody genera-
tion in rabbits. The antibody was further purified in affinity column,
against the antigen.
Cultures of 100 ml were grown at 30°C until an OD6000.4. Cells
were collected by centrifugation (3,260 g for 15 min at 4°C), and
the pellets were suspended in 10 ml of lysis buffer (50 mM Tris–HCl
pH 7.5, 100 mM NaCl and a protease inhibitor cocktail (Thermo
Scientific)) and flash-freezed in liquid nitrogen. After a soft thawing
on ice, cells were disrupted by sonication (Sonicator Fisherbrand
FB120) (alternating 3 cycles of 30-s ON with 40% amplitude and 15-
s OFF to cool down the sample). The lysates were centrifuged
(3,260 g for 5 min at 4°C) to remove unbroken cells. The super-
natant was collected and centrifuged for 1 h at 90,000 g at 4°C. After
ultracentrifugation, the supernatant corresponds to soluble material
and the pellet contains the membrane fraction. The pellet was
suspended in 200 ll of lysis buffer. Protein concentration was deter-
mined using a Bradford-based colorimetric assay (Bio-Rad 5000006)
(Bradford, 1976) with known concentrations of bovine serum albu-
min (BSA) (Sigma) as a standard. Prior to SDS–PAGE loading,
samples were diluted in 4× Laemmli sample buffer (10% b-mercap-
toethanol) (Bio-Rad) and concentrations were adjusted to load 6 lg
of membrane proteins per lane.
Samples were separated using SDS–PAGE using a 4–20% poly-
acrylamide (Mini PROTEAN TGX gel, Bio-Rad) and transferred onto
PVDF membranes (Bio-Rad). Membranes were blocked by 3% milk
in 1× TBS-T (Tris, NaCl, Tween-20) for 1 h at RT and then incu-
bated overnight at 4°C with MepS primary antibody (1:1,000 in 1×
TBS-T Milk 3%). Membranes were washed three times with 1× TBS-
T for 5 min and incubated for 1 h at RT with the secondary anti-
body (Goat Anti-Rabbit, Bio-Rad) coupled with horseradish peroxi-
dase (HRP) (1:3,000 in 1× TBS-T). Prior to signal detection,
membranes were washed three times with 1× TBS-T for 5 min and
overlaid with ECL prime detection reagent (GE Healthcare).
Microscopy, cell width measurements
For phase imaging and cell shape measurements, cells were
grown and collected at steady state at 30°C at OD6000.1. Cells
were concentrated 20 times, and 0.4 ll was transferred to a 1%
agarose pad (UltraPure Agarose; Invitrogen) prepared with LB
and preheated at 30°C. The pad was supplemented with Carb
100 lg/ml and L-arabinose 0.2% or glucose 0.2% if specified.
Phase images were obtained with an inverted epi-fluorescence
Eclipse Ti microscope (Nikon), equipped with a 100× phase
contrast objective (CFI PlanApo LambdaDM100X 1.4NA, Nikon).
Images were acquired using a sCMOS camera (Orca Flash 4.0,
Hamamatsu, Japan) with an effective pixel size of 65 nm. Cell
boundaries were detected from phase-contrast microscopy images
using the MATLAB-based cell segmentation tool Morphometrics
(SimTK) (Ursell et al, 2017).
Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with
the dataset identifiers PXD016825 (http://www.ebi.ac.uk/pride/arc
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hive/projects/PXD016825) and PXD016819 (http://www.ebi.ac.uk/
pride/archive/projects/PXD016819).
Expanded View for this article is available online.
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